ONEMEDNET CORPORATION Other Nonoperating Expense
ONEMEDNET CORPORATION (ONMD) reported Other Nonoperating Expense of $34.00 thousand for the 12-month period ending 2023-12-31, per its 10-K/A filed 2024-11-05.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2024-11-22
- ONEMEDNET CORPORATION other nonoperating expense for the quarter ending 2023-12-31 was -$9.00K.
- ONEMEDNET CORPORATION other nonoperating expense for the quarter ending 2023-09-30 was $7.00K, a 41.67% decline year-over-year.
- ONEMEDNET CORPORATION other nonoperating expense for the quarter ending 2022-12-31 was -$1.00K.
- ONEMEDNET CORPORATION other nonoperating expense for the quarter ending 2022-09-30 was $12.00K.
- ONEMEDNET CORPORATION other nonoperating expense for fiscal 2023 was $34.00K, a 13.33% increase from fiscal 2022.
- ONEMEDNET CORPORATION other nonoperating expense for fiscal 2022 was $30.00K.
| Period end | Other Nonoperating Expense 2 month | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month | Other Nonoperating Expense 9 month as first filed | Other Nonoperating Expense 12 month | Other Nonoperating Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | -$9.00K derived: 10-K/A 12 month − 8-K/A 9 month · filed 2024-11-05 | -$2.00K derived: sum of 2 quarters · filed 2024-11-22 | $34.00K 10-K/A · filed 2024-11-05 | $52.26K 10-K · filed 2024-04-09 | |||
| 2023-09-30 | $7.00K 8-K/A · filed 2024-11-22 | $43.00K 8-K/A · filed 2024-11-22 | $43.12K 10-Q · filed 2023-11-20 | ||||
| 2022-12-31 | -$1.00K derived: 10-K/A 12 month − 8-K/A 9 month · filed 2024-11-05 | $11.00K derived: sum of 2 quarters · filed 2024-11-22 | $30.00K 10-K/A · filed 2024-11-05 | $46.82K 10-K · filed 2024-04-09 | |||
| 2022-09-30 | $12.00K 8-K/A · filed 2024-11-22 | $31.00K 8-K/A · filed 2024-11-22 | $29.94K 10-Q · filed 2023-11-20 | ||||
| 2021-03-31 | $845.00 10-Q/A · filed 2021-07-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |